Irish Life Investment Managers’s Sarepta Therapeutics SRPT Stock Holding History

Irish Life Investment Managers’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$34.4K	Buy	+900	New	+$32.2K	﹤0.01%	1657

Other funds holding SRPT

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Irish Life Investment Managers's SRPT Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Sarepta Therapeutics (SRPT) in Q2 2013: 900 shares worth $34.4K. The stake represents ﹤0.01% of the portfolio and ranks #1657 among its holdings.

128 funds tracked by Wall St. Rank hold SRPT as of Q2 2013.

Irish Life Investment Managers held 900 shares of Sarepta Therapeutics worth $34.4K as of Q2 2013.
Sarepta Therapeutics was a new Irish Life Investment Managers position in Q2 2013.
Sarepta Therapeutics made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1657 holding.
128 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.